Early and long-term results of hypothermic circulatory arrest in aortic surgery: a 20-year single-centre experience

Archive ouverte

Mauduit, Marion | Anselmi, Amedeo | Soulami, Reda Belhaj | Tomasi, Jacques | Flecher, Erwan | Langanay, Thierry | Corbineau, Hervé | Rouze, Simon | Verhoye, Jean-Philippe

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. Aims The aim of this study was to document the postoperative outcomes of patients who underwent hypothermic circulatory arrest (HCA), the evolution of HCA management over time and to identify the risks factor for early mortality and postoperative stroke. Methods Four hundred and twenty-four patients who underwent aortic surgery with HCA at our institution between January 1995 and June 2016 were consecutively included. Results The main indications were degenerative aneurysm (254; 59.9%) and acute type A aortic dissection (146; 34.4%). Interventions were performed under deep (18.4 +/- 0.9 degrees C; n = 350; 82.5%) or moderate (23.9 +/- 1.9 degrees C; n = 74; 17.5%) hypothermia. Antegrade cerebral perfusion (ACP) was employed in 86 (20.3%) cases. The use of moderate hypothermia significantly increased from 2011, to become the preferred strategy in 2016. The in-hospital mortality was 12.5% and the postoperative stroke rate was 7.1%. Kaplan--Meier 5-year survival was 65.7%. Nonelective timing [odds ratio (OR) 4.05; P < 0.001], stroke (OR 3.77' P = 0.032), renal failure (OR 2.49; P = 0.023), redo surgery (2.42; P = 0.049) and CPB time (OR 1.05; P = 0.03) were independent risk factors for in-hospital mortality in multivariate analysis. Femoral cannulation was the only independent risk factor for stroke (OR 3.97; P = 0.002). The level of hypothermia and the use of ACP were not associated with either in-hospital mortality or postoperative stroke. Conclusion HCA might be widely considered to achieve a radical treatment of the aortic disease, provided that hypothermia is maintained below the 24 degrees C safety threshold and ACP is used for HCA exceeding 30 min, to ensure optimal brain, spinal cord and visceral organs protection.

Consulter en ligne

Suggestions

Du même auteur

Late Clinical and Echocardiographic Results with the Magna Ease© Pericardial Aortic Bioprosthesis

Archive ouverte | Anselmi, Amedeo | CCSD

International audience. OBJECTIVES: The population of candidates to surgical aortic valve replacement (SAVR) is evolving. The Perimount Magna Ease© bioprosthesis has been introduced relatively recently in the practi...

Porcine bioprostheses for surgical aortic valve replacement: very long-term performance of a third-generation device

Archive ouverte | Anselmi, Amedeo | CCSD

International audience. Aims We aimed at investigating the long-term durability of the Epic bioprosthesis for surgical aortic valve replacement (SAVR) in a single-centre series of 888 implantations (2001–2018), expa...

Mid-term durability of the Trifecta bioprosthesis for aortic valve replacement

Archive ouverte | Anselmi, Amedeo | CCSD

International audience. Objective To clarify the mid-term durability of the Trifecta bioprosthesis for aortic valve replacement (AVR). Methods We retrospectively analyzed the prospectively collected data of 824 cons...

Chargement des enrichissements...